Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Preleukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Neoplasms by Histologic Type 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Leukemia, B-Cell 2Leukemia 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Diseases 2Bone Marrow Diseases 2Primary Myelofibrosis 1Pathologic Complete Response 1Myeloproliferative Disorders 1Leukemia, Prolymphocytic 1Leukemia, Myelomonocytic, Chronic 1Esophageal Neoplasms 1

Interventions

pembrolizumab 2venetoclax 1taxane 1sargramostim 1rucaparib 1olaparib 1lentiviral minigene vaccine of COVID-19 coronavirus 1Platinum 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1Nivolumab 1Monatide (IMS 3015) 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Capecitabine 1Azacitidine 1Antimetabolites 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pathologic Complete Response × Patient Reported Outcome Measures × Clear all
NCT05926024 2026-03-11

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

UNC Lineberger Comprehensive Cancer Center

Active not recruiting
253 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡